Bienvenidos a CienciaPR, una red de recursos para todos los interesados en las ciencias y en Puerto Rico.
Dr. Michael J. Gonzalez is Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico. He earned a Bachelor Degree in Biology and Chemistry (Catholic University), a Masters in Cellular Biology and Biophysics (Nova University), and another Masters in Nutrition and Public Health (University of P.R.). He also has a Doctorate in Health Sciences (Lafayette University), and another Doctorate in Nutritional Biochemistry and Cancer Biology (Michigan State University). He completed a Post-Doctoral Fellowship in Geriatrics in the School of Medicine, University of Puerto Rico. Dr. Gonzalez is a Fellow of the American College of Nutrition, and has authored over 100 scientific publications. He is an active member on several scientific journal Editorial Boards, such as Biomedicina, the Journal of Orthomolecular Medicine, and Alternative Medicine Reviews. As a consultant for several companies, he has been responsible for designing formulations of nutritional supplements and pharmaceutical products. At present, he is a consultant for The Center for the Improvement of Human Functioning, in Wichita, Kansas. He has obtained several research awards for his work on Nutrition and Cancer. He is currently Co-Director of RECNAC II project, and Research Director of the InBioMed Project Initiative.
InBioMed: (Institute of Biochemical Medicine) is a Research, Education and Community Service institution. RECNAC-II Project, (which spells CANCER backwards), is InBioMed´s main research project, and its primary goal is the development of a non-toxic protocol to treat cancer and reverse its adverse effects. The Educational Branch has a part within the academic structure of the University of Puerto Rico, and external educational programs for Continuing Education for Professionals as well as for the General Public. The Service Branch includes corporative and clinical consultation.
Doctors González and Miranda-Massari, founders of InBioMed, are leaders in the development of non-toxic chemotherapy treatments for cancer. The findings of their work with Intravenous Vitamin C as an anti-cancer agent, published in 2002, were confirmed by the NIH in 2005. They published the first Phase-I clinical study utilizing Intravenous Vitamin C for treatment of terminal cancer patients in 2005, and also published in 2005 the most comprehensive review on Vitamin C and Cancer, as a follow-up on the work of two times Nobel Laureate, Dr. Linus C. Pauling.
Recursos relacionados a publicaciones científicas
Encuentra los últimos anuncios de fondos del NIH y el NSF aquí
Mira los últimos anuncios de trabajo de varias fuentes